← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2010Last known activity
Feb 25, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT03796156CollaboratorPhase 3Feb 25, 2019
- NCT03796156Overall official - principal investigatorPhase 3Feb 25, 2019
- NCT03056274Lead sponsorPhase 2/Phase 3Apr 1, 2017
- NCT03056274Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2017
- NCT01273584Study directorPhase 2/Phase 3Oct 1, 2010
- NCT01273584Lead sponsorPhase 2/Phase 3Oct 1, 2010
- NCT01273584Overall official - principal investigatorPhase 2/Phase 3Oct 1, 2010
Details
- Last known activity
- Feb 25, 2019